HUP0302881A2 - Legalább egy D-vitamint vagy D-vitamin analóg vegyületet és legalább egy kortikoszteroidot tartalmazó külsőleges gyógyszerkészítmények - Google Patents

Legalább egy D-vitamint vagy D-vitamin analóg vegyületet és legalább egy kortikoszteroidot tartalmazó külsőleges gyógyszerkészítmények

Info

Publication number
HUP0302881A2
HUP0302881A2 HU0302881A HUP0302881A HUP0302881A2 HU P0302881 A2 HUP0302881 A2 HU P0302881A2 HU 0302881 A HU0302881 A HU 0302881A HU P0302881 A HUP0302881 A HU P0302881A HU P0302881 A2 HUP0302881 A2 HU P0302881A2
Authority
HU
Hungary
Prior art keywords
vitamin
corticosteroid
analogue
composition containing
topical composition
Prior art date
Application number
HU0302881A
Other languages
English (en)
Inventor
Erik Johannes Didriksen
Gert Hoy
Original Assignee
Leo Pharma A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22918889&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0302881(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Leo Pharma A/S filed Critical Leo Pharma A/S
Publication of HUP0302881A2 publication Critical patent/HUP0302881A2/hu
Publication of HUP0302881A3 publication Critical patent/HUP0302881A3/hu
Publication of HU230005B1 publication Critical patent/HU230005B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A találmány legalább egy D-vitamint vagy D-vitamin analóg vegyületet,legalább egy kortikoszteroidot és egy viszkozitást növelő segédanyagottartalmazó, a bőrön alkalmazható, külsőleges, gél formájúgyógyszerkészítményre vonatkozik. Ó
HU0302881A 2000-10-27 2001-09-26 Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid HU230005B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24347100P 2000-10-27 2000-10-27
PCT/DK2001/000613 WO2002034235A1 (en) 2000-10-27 2001-09-26 Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid

Publications (3)

Publication Number Publication Date
HUP0302881A2 true HUP0302881A2 (hu) 2003-12-29
HUP0302881A3 HUP0302881A3 (en) 2012-03-28
HU230005B1 HU230005B1 (en) 2015-04-28

Family

ID=22918889

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0302881A HU230005B1 (en) 2000-10-27 2001-09-26 Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid

Country Status (22)

Country Link
US (1) US6787529B2 (hu)
EP (1) EP1331927B1 (hu)
JP (3) JP4451061B2 (hu)
KR (1) KR100844285B1 (hu)
CN (1) CN100382803C (hu)
AT (1) ATE380542T1 (hu)
AU (2) AU9163701A (hu)
BR (1) BRPI0114927B8 (hu)
CA (1) CA2423930C (hu)
CY (1) CY1107294T1 (hu)
CZ (1) CZ305984B6 (hu)
DE (1) DE60131881T2 (hu)
DK (1) DK1331927T3 (hu)
ES (1) ES2298264T3 (hu)
HK (1) HK1077208A1 (hu)
HU (1) HU230005B1 (hu)
IL (2) IL154888A0 (hu)
MX (1) MXPA03003511A (hu)
PL (1) PL212660B1 (hu)
PT (1) PT1331927E (hu)
RU (1) RU2271810C2 (hu)
WO (1) WO2002034235A1 (hu)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
US20090098065A1 (en) * 2000-01-11 2009-04-16 Avikam Harel Composition and methods for the treatment of skin disorders
IL154888A0 (en) * 2000-10-27 2003-10-31 Leo Pharma As Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid
US20090143328A1 (en) * 2001-08-13 2009-06-04 Mcdonald George Method of Treating Cancer by Administration of Topical Active Corticosteroids
MXPA05003805A (es) * 2002-12-17 2005-06-08 Galderma Sa Composiciones farmaceuticas que comprenden una combinacion de calcitriol y propionato de clobetasol.
US8404667B2 (en) * 2006-12-29 2013-03-26 Wisconsin Alumni Research Foundation Compounds, compositions, kits and methods of use to orally and topically treat acne and other skin conditions by 19-Nor vitamin D analog
FR2871698B1 (fr) * 2004-06-17 2008-07-04 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques et une phase huileuse
FR2871694B1 (fr) * 2004-06-17 2008-07-04 Galderma Sa Composition pharmaceutique comprenant un onguent oleagineux et deux principes actifs solubilises
FR2871700B1 (fr) * 2004-06-17 2006-11-17 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, et une phase huileuse
FR2871693B1 (fr) * 2004-06-17 2006-08-25 Galderma Sa Utilisation d'une composition pharmaceutique comprenant du calcitriol et du propionate de clobetasol pour le traitement du psoriasis
FR2871696B1 (fr) * 2004-06-17 2006-11-10 Galderma Sa Composition topique pour le traitement du psoriasis
FR2871697B1 (fr) * 2004-06-17 2007-06-29 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, au moins un silicone volatile et une phase huileuse non volatile
EP1781302A4 (en) * 2004-07-28 2010-02-17 Lipopeptide Ab NEW USE
US20060078580A1 (en) 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
NZ563270A (en) 2005-05-10 2010-11-26 Dermipsor Ltd Calcipotriol, polyethylene oxide topical compositions for the treatment of hyperproliferative epidermal diseases
EP1917072B1 (en) 2005-06-01 2013-02-27 Stiefel Research Australia Pty Ltd Vitamin formulation
MX2007015672A (es) * 2005-06-10 2008-02-20 Galderma Sa Liberacion controlada de un farmaco a traves de la piel sobre la base de una composicion topica que comprende el farmaco, una silicona formadora de pelicula y al menos un solvente volatil.
MXPA05009381A (es) * 2005-09-02 2007-03-01 Fernando Ahumada Ayala Preparaciones para el cuidado de la piel que contienen mupirocina y dipropionato de betametasona.
US8324192B2 (en) 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8679545B2 (en) 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
CA2646856C (en) 2006-03-17 2013-05-07 Leo Pharma A/S Isomerisation of pharmaceutical intermediates
MX2009002337A (es) * 2006-08-29 2009-03-20 Teva Pharma Composiciones farmacologicamente estables que incluyen compuestos que contienen vitamina d y corticosteroides con compatibilidad con bajo ph.
FR2909284B1 (fr) * 2006-11-30 2012-09-21 Galderma Sa Nouvelles compositions sous forme d'onguent sans vaseline comprenant un derive de vitamine d et eventuellement un anti-inflammatoire steroidien
ES2272198B1 (es) * 2006-12-28 2008-06-01 Laboratorios Viñas S.A. Procedimiento para la obtencion de hidrato de calcipotriol.
EP1970048A1 (en) * 2007-03-15 2008-09-17 Drug Delivery Solutions Limited Polyaphron topical composition with vitamin D
EP1970049A1 (en) * 2007-03-15 2008-09-17 Drug Delivery Solutions Limited Polyaphron topical composition with vitamin D and corticosteroid
US10265265B2 (en) 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
EP2008651A1 (en) 2007-06-26 2008-12-31 Drug Delivery Solutions Limited A bioerodible patch
US20090123551A1 (en) * 2007-11-13 2009-05-14 Meritage Pharma, Inc. Gastrointestinal delivery systems
US20100216754A1 (en) * 2007-11-13 2010-08-26 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
US8865692B2 (en) 2007-11-13 2014-10-21 Meritage Pharma, Inc Compositions for the treatment of gastrointestinal inflammation
SI3354276T1 (sl) 2007-11-13 2020-09-30 Meritage Pharma, Inc. Sestavki za zdravljenje gastrointestinalnega vnetja
US20090264392A1 (en) * 2008-04-21 2009-10-22 Meritage Pharma, Inc. Treating eosinophilic esophagitis
RU2560677C2 (ru) * 2009-12-22 2015-08-20 Лео Фарма А/С Кожная композиция, включающая аналог витамина d и смесь растворителя и поверхностно-активных веществ
BR112012015449B1 (pt) * 2009-12-22 2021-09-28 Leo Pharma A/S Suspensão de monoidrato de calcipotriol, e, processo para preparar nanocristais de monoidrato de calcipotriol
US9254296B2 (en) * 2009-12-22 2016-02-09 Leo Pharma A/S Pharmaceutical composition comprising vitamin D analogue and cosolvent-surfactant mixture
DK2579852T3 (en) 2010-06-11 2015-02-23 Leo Pharma As PHARMACEUTICAL SPRAY COMPOSITION INCLUDING AN ANALOG OF VITAMIN D AND a corticosteroid
US8968755B2 (en) 2010-10-23 2015-03-03 Joel Schlessinger Topical base and active agent-containing compositions, and methods for improving and treating skin
US8685381B2 (en) 2010-10-23 2014-04-01 Joel Schlessinger Topical base and active agent-containing compositions, and methods for improving and treating skin
CN103533962B (zh) 2011-03-14 2018-05-18 药品配送方案有限公司 一种眼用组合物
JP5897299B2 (ja) * 2011-10-14 2016-03-30 岩城製薬株式会社 ローション剤
CN104138352B (zh) * 2013-04-19 2018-02-27 江苏知原药业有限公司 卡泊三醇非水凝胶
TW201636025A (zh) * 2015-04-15 2016-10-16 Maruho Kk 皮膚用之醫藥組成物
SI3310389T1 (sl) * 2015-06-18 2020-11-30 Bausch Health Ireland Limited Topični sestavki, ki obsegajo kortikosteroid in retinoid za zdravljenje psoriaze
EP3542788A1 (en) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topical composition comprising calcipotriol and betamethasone dipropionate
KR102354028B1 (ko) 2020-05-13 2022-01-24 동국대학교 경주캠퍼스 산학협력단 건선 예방, 개선 또는 치료용 피부 외용제 조성물
CN114159567B (zh) * 2020-09-10 2023-03-31 南京海融医药科技股份有限公司 一种治疗皮肤病的混悬凝胶剂
CN115569199A (zh) * 2022-02-14 2023-01-06 南京海融医药科技股份有限公司 一种药物组合物及其制备方法和应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4569935A (en) * 1983-03-17 1986-02-11 University Of Tennessee Research Corp. Topical treatment of psoriasis with imidazole antibiotics
US4610978A (en) * 1983-03-22 1986-09-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions containing 1α-hydroxycholecalciferol for topical treatment of skin disorders and methods employing same
SE457055B (sv) * 1986-08-18 1988-11-28 Ferring Ab Topisk straalskyddsgel foer mukosa innehaallande kaerlsammandragande substanser
IL86170A (en) * 1987-05-01 1992-12-01 Elan Transdermal Ltd Preparations and compositions comprising nicotine for percutaneous administration
US4847071A (en) 1987-10-22 1989-07-11 The Procter & Gamble Company Photoprotection compositions comprising tocopherol sorbate and an anti-inflammatory agent
US5002938A (en) 1988-03-21 1991-03-26 Bristol-Myers Squibb Company Antifungal gel formulations
EP0437225B1 (de) * 1990-01-10 1994-04-20 F. Hoffmann-La Roche Ag Topische Präparate
US5185150A (en) * 1990-08-24 1993-02-09 Wisconsin Alumni Research Fdn. Cosmetic compositions containing 19-nor-vitamin D compounds
US5763428A (en) * 1990-09-21 1998-06-09 Bone Care International, Inc. Methods of treating skin disorders with novel 1a-hydroxy vitamin D4 compounds and derivatives thereof
JP2571493B2 (ja) * 1992-06-04 1997-01-16 株式会社資生堂 皮膚外用剤
AU4841193A (en) * 1992-08-28 1994-03-29 Lunar Corporation 1alpha,24(S)-dihydroxy vitamin D2, its formation and use
GB9226860D0 (en) * 1992-12-23 1993-02-17 Leo Pharm Prod Ltd Novel treatment
DE4328217C2 (de) * 1993-08-21 1996-01-11 Lohmann Therapie Syst Lts Therapeutisches System zur Behandlung der Psoriasis
US5708017A (en) * 1995-04-04 1998-01-13 Merck & Co., Inc. Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors
FR2740042B1 (fr) * 1995-10-23 1997-11-14 Oreal Support, et composition contenant ce support et un actif cosmetique ou dermatologique stabilise
JPH10158147A (ja) * 1996-11-29 1998-06-16 Kenji Nakamura 皮膚保護用の被膜組成物とそれを用いた製品
JP2001524087A (ja) * 1997-04-18 2001-11-27 クリンゲ ファーマ ジーエムビーエイチ システイニル誘導体を含有する安定化された薬剤
JPH11188054A (ja) * 1997-12-25 1999-07-13 Lion Corp 皮膚外用部材
US5990100A (en) 1998-03-24 1999-11-23 Panda Pharmaceuticals, L.L.C. Composition and method for treatment of psoriasis
FR2785284B1 (fr) * 1998-11-02 2000-12-01 Galderma Res & Dev Analogues de la vitamine d
ES2432691T3 (es) 1999-04-23 2013-12-04 Leo Pharma A/S Composición farmacéutica para uso dérmico que comprende calcipotril y betametasona para el tratamiento de la psoriasis
IL154888A0 (en) * 2000-10-27 2003-10-31 Leo Pharma As Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid

Also Published As

Publication number Publication date
DK1331927T3 (da) 2008-05-05
DE60131881T2 (de) 2008-12-04
BR0114927B1 (pt) 2017-12-05
IL154888A0 (en) 2003-10-31
KR20030048083A (ko) 2003-06-18
JP2008297310A (ja) 2008-12-11
RU2271810C2 (ru) 2006-03-20
HU230005B1 (en) 2015-04-28
ATE380542T1 (de) 2007-12-15
JP4451061B2 (ja) 2010-04-14
HK1077208A1 (en) 2006-02-10
PL360941A1 (en) 2004-09-20
JP5699169B2 (ja) 2015-04-08
MXPA03003511A (es) 2004-05-04
WO2002034235A1 (en) 2002-05-02
AU2001291637B2 (en) 2006-04-06
KR100844285B1 (ko) 2008-07-09
PL212660B1 (pl) 2012-11-30
DE60131881D1 (de) 2008-01-24
JP2004512297A (ja) 2004-04-22
IL154888A (en) 2013-12-31
BRPI0114927B8 (pt) 2021-05-25
JP5721927B2 (ja) 2015-05-20
EP1331927A1 (en) 2003-08-06
BR0114927A (pt) 2003-12-23
CA2423930A1 (en) 2002-05-02
CY1107294T1 (el) 2012-11-21
AU9163701A (en) 2002-05-06
US20020111336A1 (en) 2002-08-15
CZ305984B6 (cs) 2016-06-08
PT1331927E (pt) 2008-01-30
CN100382803C (zh) 2008-04-23
CA2423930C (en) 2009-11-24
ES2298264T3 (es) 2008-05-16
US6787529B2 (en) 2004-09-07
HUP0302881A3 (en) 2012-03-28
CN1633280A (zh) 2005-06-29
EP1331927B1 (en) 2007-12-12
JP2013075924A (ja) 2013-04-25

Similar Documents

Publication Publication Date Title
HUP0302881A2 (hu) Legalább egy D-vitamint vagy D-vitamin analóg vegyületet és legalább egy kortikoszteroidot tartalmazó külsőleges gyógyszerkészítmények
NO20042596L (no) Inbibitorer av 11-beta-hydroksy steroid dehydrogenase type 1
NO20052494D0 (no) Preparater inneholdende melatonin, gingko biloba og biotin.
YU75701A (sh) Farmaceutski preparat
AU2002231544A1 (en) Therapeutic uses of herbal compositions
HUP0301868A2 (hu) Gyógyászati készítmény, ami VIIa és XIII-as faktort tartalmaz
HUP0300905A2 (hu) Poliszacharidot tartalmazó vízmentes izzadsággátló készítmény
MXPA04004837A (es) Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1.
MXPA04004842A (es) Inhibidores de 11-(-hidroxiesteroide deshidrogenasa de tipo 1.
ATE361084T1 (de) Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
NO20052446L (no) Anvendelse av idebenone ved fremstilling av medikament
DE50312034D1 (de) Liposomale glucocorticoide
HUP0300709A2 (hu) Pemetrexedet monotioglikollal, L-ciszteinnel vagy tioglikolsavval együtt tartalmazó gyógyászati készítmény
RS44204A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
PT1414467E (pt) Tratamento topico da mastalgia
BR0010708A (pt) Glicosìdeos androgênicos e atividade androgênica dos mesmos
BRPI0611526A2 (pt) composição tópica contendo gelatina
BR0206960A (pt) Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose
AU2002212489A1 (en) Veterinary composition for the topical treatment of traumatized or inflamed skin
AU2003282868A1 (en) Crystalline 17beta-hydroxy-7alpha- (5'-methyl-2'-furyl)-pregna-4,9(11)-dien-3-one-21-carboxylic acid, gamma-lactone
EP1022017A3 (de) Kosmetische oder pharmazeutische Zubereitungen für die topische Verabreichung mit verbesserter Stabilität
HUP0204180A2 (hu) Külsőleges készítmény és alkalmazása allergiás dermatitisz kezelésére
BR0009778A (pt) Composições antifúngicas de pseudomicina e métodos para utilização das mesmas
TNSN05117A1 (en) Formulations containing melatonin, ginkgo biloba, and biotin
ATE489073T1 (de) Melatonin-tagesdosierungseinheiten